Literature DB >> 18756516

High-efficiency transfection of short hairpin RNAs-encoding plasmids into primary hippocampal neurons.

Manuel Zeitelhofer1, Daniela Karra, John P Vessey, Elmir Jaskic, Paolo Macchi, Sabine Thomas, Julia Riefler, Michael Kiebler, Ralf Dahm.   

Abstract

The transfection of expression constructs encoding a variety of transgenes is a widely used method to study gene function in cultured cells. Especially when the efficiency of the knock-down of target proteins via small interfering RNAs (siRNAs) is to be determined by quantitative Western blotting, large proportions of untransfected cells compromise the analysis. Achieving high transfection efficiencies in postmitotic cells, such as neurons, poses a particular problem in that these cells cannot be selected for the expression of the transgene following transfection. It is therefore important to develop protocols that allow for the highly efficient transfection of these cells. In the present study, we identify three important parameters that prove especially useful for chronically difficult to transfect short hairpin RNA (shRNA)-encoding plasmids: the amount and quality of the plasmid DNA used and the use of new nucleofection programs. Combining those changes increases the rate of transfected cells from less than 5% to up to approximately 80%. Importantly, these high transfection efficiencies can be obtained while maintaining good cell viability and normal cellular development. Taken together, these improvements allow for a detailed biochemical and phenotypical analysis of neurons that have been nucleoporated with a wide variety of shRNAs. 2008 Wiley-Liss, Inc.

Mesh:

Substances:

Year:  2009        PMID: 18756516     DOI: 10.1002/jnr.21840

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  8 in total

1.  Astrocytic responses to DNA delivery using nucleofection.

Authors:  H Muyderman; W P Yew; B Homkajorn; N R Sims
Journal:  Neurochem Res       Date:  2010-08-21       Impact factor: 3.996

Review 2.  Transfection techniques for neuronal cells.

Authors:  Daniela Karra; Ralf Dahm
Journal:  J Neurosci       Date:  2010-05-05       Impact factor: 6.167

3.  Stable transgene expression in primitive human CD34+ hematopoietic stem/progenitor cells, using the Sleeping Beauty transposon system.

Authors:  Teiko Sumiyoshi; Nathalia G Holt; Roger P Hollis; Shundi Ge; Paula M Cannon; Gay M Crooks; Donald B Kohn
Journal:  Hum Gene Ther       Date:  2009-12       Impact factor: 5.695

4.  Screening of small molecules affecting mammalian P-body assembly uncovers links with diverse intracellular processes and organelle physiology.

Authors:  Javier P Martínez; Gemma Pérez-Vilaró; Yazh Muthukumar; Nicoletta Scheller; Tatjana Hirsch; Randi Diestel; Heinrich Steinmetz; Rolf Jansen; Ronald Frank; Florenz Sasse; Andreas Meyerhans; Juana Díez
Journal:  RNA Biol       Date:  2013-11       Impact factor: 4.652

5.  Mammalian Pumilio 2 regulates dendrite morphogenesis and synaptic function.

Authors:  John P Vessey; Lucia Schoderboeck; Ewald Gingl; Ettore Luzi; Julia Riefler; Francesca Di Leva; Daniela Karra; Sabine Thomas; Michael A Kiebler; Paolo Macchi
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-28       Impact factor: 11.205

6.  Non-viral Vector Mediated RNA Interference Technology for Central Nerve System Injury.

Authors:  Christian Macks; Jeoung Soo Lee
Journal:  DNA RNA Nanotechnol       Date:  2016-08-25

7.  Microporation is an efficient method for siRNA-induced knockdown of PEX5 in HepG2 cells: evaluation of the transfection efficiency, the PEX5 mRNA and protein levels and induction of peroxisomal deficiency.

Authors:  Barbara Ahlemeyer; Julia-Franziska Vogt; Vera Michel; Petra Hahn-Kohlberger; Eveline Baumgart-Vogt
Journal:  Histochem Cell Biol       Date:  2014-09-17       Impact factor: 4.304

8.  Nucleofection of whole murine retinas.

Authors:  Iria Maria Gomez-Touriño; Ana Senra; Francisco Garcia
Journal:  Cytotechnology       Date:  2012-11-07       Impact factor: 2.058

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.